glp-1 food industry news today What to know about packaged foods aimed at users of weight-loss drugs Food Companies Are Creating Brand-New

Patients receiving Foundayo 17.2 mg lost an average of 19.7 pounds, compared with 11.0 pounds among those receiving oral semaglutide 14 mg, corresponding to a 73.6% greater relative weight reduction. Notably, 37.1% of patients receiving the higher dose of Foundayo achieved an A1C below 5.7%, a threshold generally considered within the normal glycemic range, compared with 12.5% of patients receiving oral semaglutide. "ACHIEVE-3 provides the first head-to-head data on oral GLP-1s in type 2 diabetes, with orforglipron showing greater A1C and weight reductions than oral semaglutide," said Julio Rosenstock, MD, clinical professor of medicine at the University of Texas Southwestern Medical Center and lead investigator for ACHIEVE-3. What did the additional ACHIEVE studies show

While no single food or food group has been proven to outright kill zombie cells, registered dietitian Marjorie Nolan Cohn says research overwhelmingly supports a whole food diet for slowing their accumulation

A high-glycemic load diet is linked with more depression symptoms, total mood disturbance, and fatigue compared to a low-glycemic load diet, especially in people who are overweight or obese

The risks of not getting enough protein while taking a GLP-1 While some loss of muscle mass is bound to occur with dropping pounds on a GLP-1, if youre not supplying your body with substantial protein, youre at risk of losing even more of this essential tissue